Page last updated: 2024-12-06

anthiolimine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

anthiolimine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72062
MeSH IDM0045474

Synonyms (23)

Synonym
succinic acid, mercapto-, thioantimonate(iii), dilithium salt
mercaptosuccinic acid antimonate (iii) hexalithium salt
rp 110 l
lithium antimoniothiomalate
anthiomaline
stibine, tris((1,2-dicarboxyethyl)thio)-, hexalithium salt
antimony lithium thiomalate
butanedioic acid, 2,2',2''-(stibylidynetris(thio))tris-, hexalithium salt
anthiolimine
antiolimina [inn-spanish]
anthioliminum [inn-latin]
hexalithium 5,5',5''-stibeintriyltris(2-thiosuccinat)
tris((1,2-dicarboxyethyl)thio)stibine hexalithium salt
lithium antimony thiomalate
mercaptosuccinic acid s-antimony derivative lithium salt
ai3-15246
einecs 206-173-0
anthioliminum
antiolimina
unii-tx973xby8n
2,2',2''-(stibilidynetris(thio)tris-butanedioic acid) hexalithium salt
lithium 2,2',2''-stibinetriyltris(sulfanediyl)trisuccinate
Q27290476

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" In vivo effectiveness may depend on bioavailability of Sb in the host and the direct action on the parasite, reflected by its in vitro activity."( Antitrypanosomal activity of trivalent antimonials in vitro and its significance.
Ercoli, N; Minelli, EB; Olivo, N, 1980
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (95.00)18.7374
1990's1 (5.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]